What another failed drug trial means for Novavax’s future


Novavax remains optimistic about the findings of the study. Analysts and investors aren't so sure.

Previous Local builders donate $500K for AdventHealth family center
Next Le Bonheur plans two-story, $38M expansion of Heart Institute